What is the current valuation of the US Epilepsy Surgery Market?

The US Epilepsy Surgery Market was valued at 223.2 USD Million in 2024. Read More

What is the projected market valuation for the US Epilepsy Surgery Market by 2035?

The market is projected to reach 396.0 USD Million by 2035. Read More

What is the expected CAGR for the US Epilepsy Surgery Market during the forecast period?

The expected CAGR for the US Epilepsy Surgery Market from 2025 to 2035 is 5.35%. Read More

Which surgical technique segment is anticipated to have the highest valuation?

The Minimally Invasive Surgery segment is expected to range from 80.0 to 150.0 USD Million. Read More

What are the key players in the US Epilepsy Surgery Market?

Key players include Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson. Read More

How does the valuation of Resective Surgery compare to other surgery types?

Resective Surgery is projected to be valued between 80.0 and 140.0 USD Million, indicating strong performance. Read More

What is the valuation range for the Pediatric patient age group in the market?

The Pediatric segment is expected to be valued between 40.0 and 70.0 USD Million. Read More

Which indication segment is projected to have the highest market valuation?

The Drug-resistant Epilepsy segment is anticipated to range from 80.0 to 140.0 USD Million. Read More

What is the expected valuation for Rehabilitation Services in postoperative care?

Rehabilitation Services is projected to be valued between 103.2 and 176.0 USD Million. Read More

How does the Adult patient age group valuation compare to Geriatric patients?

The Adult segment is expected to be valued between 130.0 and 220.0 USD Million, significantly higher than the Geriatric segment. Read More

US Epilepsy Surgery Market

ID: MRFR/HC/17816-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Epilepsy Surgery Market Research Report: Size, Share, Trend Analysis By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT) and By End Users (Hospitals & Clinics, Specialty Centers) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Surgery Type (USD Million)
  1. 4.1.1 Resective Surgery
  2. 4.1.2 Functional Surgery
  3. 4.1.3 Laser Surgery
  4. 4.1.4 Hemispherectomy
2. 4.2 Healthcare, BY Indication (USD Million)
  1. 4.2.1 Drug-resistant Epilepsy
  2. 4.2.2 Focal Epilepsy
  3. 4.2.3 Generalized Epilepsy
  4. 4.2.4 Neurodegenerative Disorders
3. 4.3 Healthcare, BY Patient Age Group (USD Million)
  1. 4.3.1 Pediatric
  2. 4.3.2 Adult
  3. 4.3.3 Geriatric
4. 4.4 Healthcare, BY Surgical Technique (USD Million)
  1. 4.4.1 Open Surgery
  2. 4.4.2 Minimally Invasive Surgery
  3. 4.4.3 Endoscopic Surgery
5. 4.5 Healthcare, BY Postoperative Care (USD Million)
  1. 4.5.1 Inpatient Care
  2. 4.5.2 Outpatient Care
  3. 4.5.3 Rehabilitation Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NeuroPace (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 LivaNova (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cleveland Clinic (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Epilepsy Foundation (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY SURGERY TYPE
3. 6.3 US MARKET ANALYSIS BY INDICATION
4. 6.4 US MARKET ANALYSIS BY PATIENT AGE GROUP
5. 6.5 US MARKET ANALYSIS BY SURGICAL TECHNIQUE
6. 6.6 US MARKET ANALYSIS BY POSTOPERATIVE CARE
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY SURGERY TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY SURGERY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SURGERY TYPE, 2026-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
  3. 7.2.3 BY PATIENT AGE GROUP, 2026-2035 (USD Million)
  4. 7.2.4 BY SURGICAL TECHNIQUE, 2026-2035 (USD Million)
  5. 7.2.5 BY POSTOPERATIVE CARE, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US US Epilepsy Surgery Market Segmentation

US Epilepsy Surgery Market By Surgery Type (USD Million, 2026-2035)

Resective Surgery
Functional Surgery
Laser Surgery
Hemispherectomy

US Epilepsy Surgery Market By Indication (USD Million, 2026-2035)

Drug-resistant Epilepsy
Focal Epilepsy
Generalized Epilepsy
Neurodegenerative Disorders

US Epilepsy Surgery Market By Patient Age Group (USD Million, 2026-2035)

Pediatric
Adult
Geriatric

US Epilepsy Surgery Market By Surgical Technique (USD Million, 2026-2035)

Open Surgery
Minimally Invasive Surgery
Endoscopic Surgery

US Epilepsy Surgery Market By Postoperative Care (USD Million, 2026-2035)

Inpatient Care
Outpatient Care
Rehabilitation Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”